First Comparison of Amulet and Watchman FLX LAA Closure Devices
By A Mystery Man Writer
Description
Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation
Diagnostic and Interventional Cardiology
Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR
Diagnostic and Interventional Cardiology
Left Atrial Appendage (LAA) Occluders
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
Structural Heart Occluders
Diagnostic and Interventional Cardiology
First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
Structural Heart Occluders
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
from
per adult (price varies by group size)